Bristol Myers Squibb logo
Bristol Myers Squibb · Life sciences

Global Medical Affairs Strategy Asset Lead

Bristol Myers Squibb US Posted Nov 17, 2026
Location
US
Workplace
On-site / per employer
Posted
Nov 17, 2026

Life at BMS

At RayzeBio, every day is an opportunity to ignite meaningful change. As a wholly-owned subsidiary of Bristol Myers Squibb, RayzeBio blends the nimble, pioneering spirit of an emergent biotech with the global expertise and resources of a leading innovator in oncology. Our mission is to develop transformative radiopharmaceutical therapies that offer new hope for patients living with cancer.

Here, you’ll join a multidisciplinary team where your ideas are valued, your expertise is amplified, and collaboration is at the heart of everything we do. From day one, expect to make an immediate impact—on our science, on our teams, and most importantly, on patients. Learn more about RayzeBio: https://careers.bms.com/rayzebio/

RayzeBio, a Bristol Myers Squibb company, is a dynamic biotechnology company headquartered in San Diego, CA. The company is focused on improving survival of people with cancer by harnessing the power of targeted radioisotopes. RayzeBio is developing innovative drugs against targets of solid tumors. Led by a successful and experienced entrepreneurial team, RayzeBio aims to be the global leader in radiopharmaceuticals

We are seeking a Global Medical Affairs Strategy Asset Lead to support global medical strategy and enrollment for one pipeline program. This important role involves shaping and executing the global medical strategy for our assets and ensuring scientific excellence. The Global Medical Affairs Strategy Asset Lead will collaborate closely with cross-functional teams, including Research & Development, Commercial, and Corporate Communications.

Key Responsibilities

  • ✓Collaborate closely with R&D, Commercial, Access, and Corporate Communications to shape pipeline and portfolio strategies, ensuring alignment of medical plans with portfolio objectives.
  • ✓Serve as the key medical representative on clinical development teams and study execution teams, providing scientific and medical expertise to support cross-functional deliverables such as early development strategy, trial designs, and recruitment.
  • ✓Supports development of the integrated medical evidence plan for an early pipeline asset
  • ✓Oversee medical communication strategy and pull through in publications, congress planning, advisory boards, and KOL engagement.
  • ✓Provide medical leadership across the medical matrix team, including medical positioning, field medical engagement, and external education.
  • ✓Engage with key external thought leaders, medical organizations, and patient advocacy groups to inform strategy and uphold scientific credibility.
  • ✓Mentor and develop medical staff within a matrixed environment.

Qualifications & Experience

  • ✓MD, DO, PharmD, or PhD (or equivalent scientific or medical training)
  • ✓3-5+ years in medical affairs in oncology pharmaceutical/biotech. Experience with radiopharmaceuticals and/or prostate cancer is preferred.
  • ✓Demonstrated ability to interpret and clearly communicate complex clinical and scientific data.
  • ✓Experience partnering with and engaging external experts.
  • ✓Strong written and verbal communication skills, with experience in scientific presentations.
  • ✓Proven ability to collaborate cross‑functionally within a matrixed organization and manage multiple competing priorities.
  • ✓Comfort operating in ambiguity and adapting to emerging data.
  • ✓Applies AI to improve team execution and decision‑making

We hire for skills and capabilities, not just credentials – if this role excites you, but doesn’t perfectly match your resume, we encourage you to apply anyway.

Compensation Overview

Remote - United States - US: $173,217 - $209,899

Originally posted by Bristol Myers Squibb. View original posting